Xcout IntelSHL Telemedicine Ltd.
Established in 1987 and headquartered in Tel Aviv, Israel, SHL Telemedicine Ltd. is a global provider specializing in the development and distribution of individual remote healthcare solutions across Israel, Europe, and other international markets. The company's extensive product line includes a variety of advanced electrocardiogram (ECG) devices designed for personal use: Smartheart, a mobile 12-lead ECG capable of identifying heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter; Cardio'B, a portable 12-lead ECG unit; and the Cardio Beeper 12/12, a handheld device that transmits full ECG readings to a monitoring center. Beyond cardiac monitoring, SHL offers a suite of other remote diagnostic tools, such as a central communication module for relaying medical data from various devices to its telemedicine centers, TeleWeight for trans-telephonic weight tracking, TelePress for remote blood pressure measurements, TeleBreather for assessing lung function, and the TelePulse Oximeter for measuring blood oxygen saturation and pulse rate. These telemedicine services and devices are delivered to subscribers via both telephonic and internet communication channels. The company caters to a diverse range of clients, including individual patients, health insurance providers, hospitals, clinics, medical practitioners, and other healthcare organizations. SHL Telemedicine is also engaged in key collaborative research efforts. It partners with the Mayo Clinic to evaluate the efficacy of its FDA-approved SmartHeart in reducing emergency department visits, re-hospitalizations, and major adverse cardiovascular events in post-heart attack patients over a 90-day period. Additionally, the company is working with the Hebrew University of Jerusalem and the Hadassah Medical Center to create an artificial intelligence tool designed to predict future life-threatening cardiac incidents based on 12-Lead ECG monitoring.
Subscribe to see SHL Telemedicine Ltd.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
SHL Telemedicine Ltd. at a glance
SHL Telemedicine Ltd. is a healthtech company headquartered in Tel Aviv, Israel. It is publicly listed (SHLTN) with a market capitalisation of $48.9M. Xcout tracks 9 named people at SHL Telemedicine Ltd., including DAVID ARNON (CEO).
SHL Telemedicine Ltd. leadership
- DAVID ARNONCEO
- Lior HaalmanCFO
- Dr. Itamar OfferChairman of the Board of Directors
- Martin BartetzkoManaging Director SHL Telemedizin, Germany
- Dr. Yishay SzekelyMedical Director SHL Telemedicine
- IDO NOUBERGERMember of the Board of Directors
3 more named people on record for SHL Telemedicine Ltd., with roles, board committees and tenure — see the full roster →
SHL Telemedicine Ltd. competitors
A few of SHL Telemedicine Ltd.'s closest competitors — see the full list of competitors and alternatives →
Eko Health is a U.S. digital health company that develops smart stethoscopes and clinical software using artificial intelligence to help detect heart and lung conditions. Its products are intended for healthcare professionals, including primary care clinicians and cardiologists.
Cardiologs is a medical technology company headquartered in Paris, France, acquired by Philips Healthcare. It is on a mission to democratize expert cardiac care using medical-grade artificial intelligence, employing a team largely composed of software engineers and data scientists.
Cardiosense, Inc. is a Chicago-based digital health company that leverages artificial intelligence and multi-sensor devices. It recently completed a $15.1 million Series A financing round to advance its medical technology solutions.
Shen AI is a software development company that turns ordinary smartphones into camera-based health screening devices to deliver remote wellness and vital sign assessments.
Doctomatic provides a regulatory-grade, AI-powered ingestion layer designed to convert medical device readings into structured vitals. This service enables tech companies to utilize artificial intelligence for clinicians.
Impact Vitals is a digital healthcare and medical technology company that develops artificial intelligence-based solutions to transform physiologic data into vital signs for patient monitoring. The company provides software and tools designed to help caregivers detect early patient deterioration and improve clinical outcomes in hospitals.
Get SHL Telemedicine Ltd.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on SHL Telemedicine Ltd. in Xcout Intel
- 9 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access